Kasra Kasraian
Fortuna: 149 721 $ al 31/08/2026
Fortuna: 149 721 $ al 31/08/2026
Kasra Kasraian is currently Chief Technical Officer at PepGen Inc. Formerly, Dr. Kasraian was Senior VP-Quality, Regulatory & CMC Sciences at Genetix Biotherapeutics, Inc. Dr. Kasraian completed undergraduate and doctorate degrees at the University of Kentucky.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PEPGEN INC. 0,07 % | 21/05/2026 | 50.074 ( 0,07 % ) | 149 721 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PEPGEN INC. | Director Técnico/Científico/I+D | 20/05/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Consejero General | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
bluebird bio, Inc.
bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
University of Kentucky
University of Kentucky Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PepGen Inc.
PepGen Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company which develops oligonucleotide therapeutics for treatment of severe neuromuscular and neurologic diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.